Tuesday, Affymetrix Inc. said that it granted Epigenomics AG non-exclusive access to its microarray technology to develop and market microarray-based in-vitro diagnostic or IVD tests for oncology and other indications.
Trading Markets Live
Simplifying Global Compliance
Recommended Products
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
This management report includes more than 650 items organized in three sections covering all aspects of quality manufacturing.
Biological Risk Evaluation and Management for Medical Devices
Report shows how the FDA incorporates the two ISO standards in its medical device development policy, how the EU version of the two standards differs in significant ways and how the EU Medical Device Regulation may require further changes in the European standards.
Editor's Picks
Gramercy’s Nitinol Staple System Cleared by FDA
The device provides an array of sterile symmetric and asymmetric, barbed and smooth staples.
Stakeholders Offer Feedback on New National Drug Code Format
Among other options, the agency proposed a new, expanded 12-digit format.
FDAnews Device Daily Bulletin
AFFYMETRIX GRANTS EPIGENOMICS NONEXCLUSIVE ACCESS TO ITS MICRO ARRAY TECHNOLOGY
June 29, 2006
